tetano
Editor, Senior Moderator
Pediatr Infect Dis J
. 2024 Oct 2.
doi: 10.1097/INF.0000000000004560. Online ahead of print. Impact of Respiratory Syncytial Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection on Clinical Severity and Outcomes Among Children Hospitalized With Lower Respiratory Tract Infections in Soweto, South Africa
Kitso-Lesedi Mrubata[SUP] 1 [/SUP], Vicky Bailie[SUP] 2 3 [/SUP], Fatima Solomon[SUP] 2 3 [/SUP], Alane Izu[SUP] 2 3 [/SUP], Musawenkosi Ncube[SUP] 2 3 [/SUP], Marta C Nunes[SUP] 2 4 [/SUP], Ziyaad Dangor[SUP] 2 3 [/SUP], Shabir A Madhi[SUP] 2 3 [/SUP], David P Moore[SUP] 1 2 [/SUP], Charl Verwey[SUP] 1 2 [/SUP]
Affiliations
Background: No data are available regarding the interplay and clinical manifestations of respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) coinfection in African children. We compared clinical characteristics and outcomes between RSV-only, SARS-CoV-2-only and RSV/SARS-CoV-2 coinfection lower respiratory tract infections (LRTI) in hospitalized African children.
Methods: Prospective surveillance of children (0-59 months) hospitalized with severe LRTI was undertaken between March 1, 2020, and March 31, 2023, in Johannesburg, South Africa. Nasopharyngeal swabs for respiratory viruses and clinical data were collected, and clinical characteristics and outcomes were described and compared. Respiratory index of severity in children (RISC) scores were calculated for HIV-uninfected children, and covariates associated with high RISC scores (≥5) were evaluated.
Results: Seven thousand four hundred fifty-six children [6.1 months (interquartile range, 14.4-18.6); 57.7% male] were enrolled, 1372 (18.4%) testing RSV+/SARS-CoV-2- (RSV only), 223 (3.0%) RSV-/SARS-CoV-2+ (SARS-CoV-2-only) and 28 (0.4%) RSV+/SARS-CoV-2+ (RSV/SARS-CoV-2 coinfection). Children with RSV only and RSV/SARS-CoV-2 coinfection were more likely to present with bronchiolitis than those with SARS-CoV-2-only (673/1372 and 15/28 vs. 46/223; P < 0.001). Children with RSV/SARS-CoV-2 coinfection had more severe disease than those with RSV or SARS-CoV-2-only, as well as a higher RISC score than SARS-CoV-2-only. Weight-for-age Z scores [adjusted risk ratio (aRR): 0.92], room air saturations (aRR: 0.988) and RSV+ status (aRR: 1.40) were independently associated with severe disease.
Conclusions: Although both RSV and SARS-CoV-2 LRTI occurred commonly, coinfection did not. Children with RSV/SARS-CoV-2 coinfection had a higher prevalence of severe LRTI than those with RSV or SARS-CoV-2-only. These findings reinforce the urgent need for safe and effective RSV and SARS-CoV-2 vaccines, especially in children in low- and middle-income countries, where the burden of disease is the highest and the access to medical resources the lowest.
. 2024 Oct 2.
doi: 10.1097/INF.0000000000004560. Online ahead of print. Impact of Respiratory Syncytial Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection on Clinical Severity and Outcomes Among Children Hospitalized With Lower Respiratory Tract Infections in Soweto, South Africa
Kitso-Lesedi Mrubata[SUP] 1 [/SUP], Vicky Bailie[SUP] 2 3 [/SUP], Fatima Solomon[SUP] 2 3 [/SUP], Alane Izu[SUP] 2 3 [/SUP], Musawenkosi Ncube[SUP] 2 3 [/SUP], Marta C Nunes[SUP] 2 4 [/SUP], Ziyaad Dangor[SUP] 2 3 [/SUP], Shabir A Madhi[SUP] 2 3 [/SUP], David P Moore[SUP] 1 2 [/SUP], Charl Verwey[SUP] 1 2 [/SUP]
Affiliations
- PMID: 39733274
- DOI: 10.1097/INF.0000000000004560
Background: No data are available regarding the interplay and clinical manifestations of respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) coinfection in African children. We compared clinical characteristics and outcomes between RSV-only, SARS-CoV-2-only and RSV/SARS-CoV-2 coinfection lower respiratory tract infections (LRTI) in hospitalized African children.
Methods: Prospective surveillance of children (0-59 months) hospitalized with severe LRTI was undertaken between March 1, 2020, and March 31, 2023, in Johannesburg, South Africa. Nasopharyngeal swabs for respiratory viruses and clinical data were collected, and clinical characteristics and outcomes were described and compared. Respiratory index of severity in children (RISC) scores were calculated for HIV-uninfected children, and covariates associated with high RISC scores (≥5) were evaluated.
Results: Seven thousand four hundred fifty-six children [6.1 months (interquartile range, 14.4-18.6); 57.7% male] were enrolled, 1372 (18.4%) testing RSV+/SARS-CoV-2- (RSV only), 223 (3.0%) RSV-/SARS-CoV-2+ (SARS-CoV-2-only) and 28 (0.4%) RSV+/SARS-CoV-2+ (RSV/SARS-CoV-2 coinfection). Children with RSV only and RSV/SARS-CoV-2 coinfection were more likely to present with bronchiolitis than those with SARS-CoV-2-only (673/1372 and 15/28 vs. 46/223; P < 0.001). Children with RSV/SARS-CoV-2 coinfection had more severe disease than those with RSV or SARS-CoV-2-only, as well as a higher RISC score than SARS-CoV-2-only. Weight-for-age Z scores [adjusted risk ratio (aRR): 0.92], room air saturations (aRR: 0.988) and RSV+ status (aRR: 1.40) were independently associated with severe disease.
Conclusions: Although both RSV and SARS-CoV-2 LRTI occurred commonly, coinfection did not. Children with RSV/SARS-CoV-2 coinfection had a higher prevalence of severe LRTI than those with RSV or SARS-CoV-2-only. These findings reinforce the urgent need for safe and effective RSV and SARS-CoV-2 vaccines, especially in children in low- and middle-income countries, where the burden of disease is the highest and the access to medical resources the lowest.